Adenoviral vectors encoding erythropoietin and their use in gene therapy
作者： Rocco Savino , Gennaro Ciliberto , Nicola La Monica
DOI:
关键词: Medicine 、 Erythropoietin 、 Chronic renal failure 、 Immunology 、 Cell 、 Genetic enhancement
摘要: Helper dependant adenoviral vectors encoding erythropoietin (epo) provide high levels of epo to achieve a long-term therapeutically effective dosage, and allow for repeat administration patients with disorders such as anaemia Chronic Renal Failure (CRF), anaemias due beta-thalassaemia, sickle cell (SCA).
lens.org 参考文章(18)
Inder M Verma, Nikunj Somia, None, Gene therapy -- promises, problems and prospects Nature. ,vol. 389, pp. 239- 242 ,(1997) , 10.1038/38410
Stephen F. Hardy, Helper-free, totally defective adenovirus for gene therapy ,(1997)
Matthew Weitzman, Krishna J. Fisher, James M. Wilson, Shu-Jen Chen, Adenovirus and methods of use thereof ,(1995)
Sandeep K. Tripathy, Hugh B. Black, Eugene Goldwasser, Jeffrey M. Leiden, Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors Nature Medicine. ,vol. 2, pp. 545- 550 ,(1996) , 10.1038/NM0596-545
Domenico Maione, Maciej Wiznerowicz, Paola Delmastro, Riccardo Cortese, Gennaro Ciliberto, Nicola La Monica, Rocco Savino, None, Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector Human Gene Therapy. ,vol. 11, pp. 859- 868 ,(2000) , 10.1089/10430340050015473
S. Kochanek, P. R. Clemens, K. Mitani, H. H. Chen, S. Chan, C. T. Caskey, A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 5731- 5736 ,(1996) , 10.1073/PNAS.93.12.5731
Hsiao-Huei Chen, Lisa M. Mack, So-Young Choi, Marcia Ontell, Stefan Kochanek, Paula R. Clemens, DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle. Human Gene Therapy. ,vol. 10, pp. 365- 373 ,(1999) , 10.1089/10430349950018814
Stephen L. Eck, The prospects for gene therapy. Hospital Practice. ,vol. 34, pp. 67- 75 ,(1999) , 10.3810/HP.1999.10.170
Gudrun Schiedner, Núria Morral, Robin J. Parks, Ying Wu, Suzanne C. Koopmans, Claire Langston, Frank L. Graham, Arthur L. Beaudet, Stefan Kochanek, Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity Nature Genetics. ,vol. 18, pp. 180- 183 ,(1998) , 10.1038/NG0298-180
H.-H. Chen, L. M. Mack, R. Kelly, M. Ontell, S. Kochanek, P. R. Clemens, Persistence in muscle of an adenoviral vector that lacks all viral genes Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 1645- 1650 ,(1997) , 10.1073/PNAS.94.5.1645